FASCINATION ABOUT SEMAGLUTIDE VIAL 7-12 BUNDLE

The demo achieved each its primary endpoints, with semaglutide two.4 mg demonstrating statistically important and remarkable improvements in liver fibrosis without having worsening of steatohepatitis, along with resolution of steatohepatitis without any worsening of liver fibrosis in those with MASH as compared to placebo.1Pancreatitis and gallblad